{"id":7456,"date":"2005-04-18T10:07:55","date_gmt":"2005-04-18T09:07:55","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=7456"},"modified":"2014-05-21T18:19:01","modified_gmt":"2014-05-21T18:19:01","slug":"12th-conference-on-retrovirus-and-opportunistic-infections-22-25-february-boston-2005","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/7456","title":{"rendered":"12th Conference on Retrovirus and Opportunistic Infections, 22-25 February, Boston, 2005"},"content":{"rendered":"<p><a href=\"https:\/\/i-base.info\/htb\/keyword\/croi-2005\">Reports from the conference<\/a><\/p>\n<p><strong>As is customary for this scientific meeting, Retrovirus this year provided an opportunity for important research.<\/strong><\/p>\n<p>Abstracts from this meeting are posted to the conference website, and many pdf for poster presentations are also already online:<br \/>\n<a href=\"http:\/\/www.retroconference.org\">http:\/\/www.retroconference.org<\/a><\/p>\n<p>There was a wealth of exciting data on new compounds with an indication to work against currently resistant HIV, and important overviews that this year are available as online webcasts, with slides.<br \/>\n<a href=\"http:\/\/www.retroconference.org\/2005\/Pages\/webcasts.htm\">http:\/\/www.retroconference.org\/2005\/Pages\/webcasts.htm<\/a><\/p>\n<p>Particularly recommended presentations include:<\/p>\n<p>February 23, 2005<\/p>\n<p><strong>Plenary: Nevirapine and PMTCT <\/strong><\/p>\n<ul>\n<li>Controversies in the use of nevirapine for the prevention of mother-to-child transmission &#8211; James McIntyre<\/li>\n<\/ul>\n<p><strong>Symposium: Chemokine Receptor Blockade: Bench to Bedside<\/strong><\/p>\n<ul>\n<li>Preclinical development of chemokine receptor inhibitors &#8211; Donald E Mosier<\/li>\n<li>Clinical activity and efficacy trials of chemokine receptor inhibitors &#8211; Daniel Kuritzkes<\/li>\n<\/ul>\n<p><strong>Symposium: Heart and HAART<\/strong><\/p>\n<ul>\n<li>Cardiovascular risk prediction in the general population &#8211; Jorge Plutzky<\/li>\n<li>Cardiovascular outcomes in HIV infection &#8211; Jens D Lundgren<\/li>\n<li>Managing cardiovascular risk and lipid disorders &#8211; Esteban Martinez<\/li>\n<\/ul>\n<p>February 24, 2005<\/p>\n<p><strong>Plenary: Lipodystrophy<\/strong><\/p>\n<ul>\n<li>Fitting the pieces of the puzzle &#8211; Peter Reiss<\/li>\n<\/ul>\n<p><strong>Symposium: Critical Paediatric Issues in Developing Countries<\/strong><\/p>\n<ul>\n<li>Safer breastfeeding for babies born to HIV-positive mothers: part of the answer to a dilemma &#8211; Jean Humphrey<\/li>\n<li>Is early diagnosis of HIV infection feasible in resource-limited settings? \u2013 Christine Rouzioux<\/li>\n<li>Paediatric antiretroviral therapy: challenges and triumphs &#8211; Diana Gibb<\/li>\n<\/ul>\n<p><strong>Special Symposium: Transmitted HIV-1 Drug Resistance and Rapid Disease Progression<\/strong><\/p>\n<ul>\n<li>Introductory remarks and summary of case report of recent infection by a multi-drug resistant, dual-tropic HIV-1 in association with rapid progression to AIDS &#8211; David Ho<\/li>\n<li>Variations in the natural history of HIV infection in the NIAID Multicenter AIDS Cohort Study (MACS) and the Women\u2019s Interagency HIV Study (WIHS) &#8211; Stephen Gange<\/li>\n<li>Variations in the natural history of HIV seroconverters in US military cohorts &#8211; Matthew Dolan<\/li>\n<li>Transmission of drug resistant HIV: frequency, transmissibility, and fitness &#8211; Andrew Leigh Brown<\/li>\n<li>Public health aspects of the NYC case &#8211; Harold Jaffe<\/li>\n<\/ul>\n<p>With over 900 studies and presentations we are only able to include a few reports in this issue of HTB. Further reports will follow in the next issue.<\/p>\n<p>The conference is the focus of many online web reports which are also recommended.<\/p>\n<p>Amongst the most useful include:<\/p>\n<p>National AIDS Treatment Advocacy Project &#8211; NATAP.<br \/>\n<a href=\"http:\/\/www.natap.org\">http:\/\/www.natap.org<\/a><\/p>\n<p>The Body<br \/>\n<a href=\"http:\/\/www.thebody.org\">http:\/\/www.thebody.org<\/a><\/p>\n<p>HIV and Hepatitis.com<br \/>\n<a href=\"http:\/\/www.hivandhepatitis.com\">http:\/\/www.hivandhepatitis.com<\/a><\/p>\n<p>Medscape<br \/>\n<a href=\"http:\/\/www.medscape.com\">http:\/\/www.medscape.com<\/a><\/p>\n<p>Clinical Care Options<br \/>\n<a href=\"http:\/\/www.clinicaloptions.com\">http:\/\/www.clinicaloptions.com<\/a><\/p>\n<p>Reports in this issue include:<\/p>\n<ul>\n<li><a title=\"Permanent link to Developments in nevirapine use in MTCT reduction\" href=\"https:\/\/i-base.info\/htb\/7452\" rel=\"bookmark\">Developments in nevirapine use in MTCT reduction<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Mashi study \u2013 late breakers on breastfeeding\" href=\"https:\/\/i-base.info\/htb\/7450\" rel=\"bookmark\">Mashi study \u2013 late breakers on breastfeeding<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Maternal health and infant mortality\" href=\"https:\/\/i-base.info\/htb\/7448\" rel=\"bookmark\">Maternal health and infant mortality<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Paediatric care in lower income settings\" href=\"https:\/\/i-base.info\/htb\/7446\" rel=\"bookmark\">Paediatric care in lower income settings<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Tenofovir not linked to bone toxicity in children followed for one year\" href=\"https:\/\/i-base.info\/htb\/7444\" rel=\"bookmark\">Tenofovir not linked to bone toxicity in children followed for one year<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Gut memory CD4 T cells implicated in a central role for HIV disease pathology: dramatic impact prior to seroconversion\" href=\"https:\/\/i-base.info\/htb\/7442\" rel=\"bookmark\">Gut memory CD4 T cells implicated in a central role for HIV disease pathology: dramatic impact prior to seroconversion<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Case of multi-drug resistant (MDR) rapid progressor\" href=\"https:\/\/i-base.info\/htb\/7439\" rel=\"bookmark\">Case of multi-drug resistant (MDR) rapid progressor<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Case report of antibody reversion and negative viral load four-years after treatment discontinuation\" href=\"https:\/\/i-base.info\/htb\/7437\" rel=\"bookmark\">Case report of antibody reversion and negative viral load four-years after treatment discontinuation<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to 24-week efficacy of TMC114 in PI-experienced patients\" href=\"https:\/\/i-base.info\/htb\/6972\" rel=\"bookmark\">24-week efficacy of TMC114 in PI-experienced patients<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Maturation inhibitor shows anti-HIV activity in single dose pilot study\" href=\"https:\/\/i-base.info\/htb\/7433\" rel=\"bookmark\">Maturation inhibitor shows anti-HIV activity in single dose pilot study<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to New antiretrovirals at 12th CROI\" href=\"https:\/\/i-base.info\/htb\/7429\" rel=\"bookmark\">New antiretrovirals at 12th CROI<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Absolute risk is modest, but cumulative cardiovascular risk of HAART over five years is similar to 'ever smoked': new data on gender and age\" href=\"https:\/\/i-base.info\/htb\/7427\" rel=\"bookmark\">Absolute risk is modest, but cumulative cardiovascular risk of HAART over five years is similar to &#8216;ever smoked&#8217;: new data on gender and age<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Omega-3 supplement effective to reduce triglycerides\" href=\"https:\/\/i-base.info\/htb\/8581\" rel=\"bookmark\">Omega-3 supplement effective to reduce triglycerides<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Entecavir is effective against 3TC-resistant hepatitis B\" href=\"https:\/\/i-base.info\/htb\/7424\" rel=\"bookmark\">Entecavir is effective against 3TC-resistant hepatitis B<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Switch to tenofovir from AZT or d4T improves fat loss and improves lipid parameters compared to abacavir\" href=\"https:\/\/i-base.info\/htb\/8583\" rel=\"bookmark\">Switch to tenofovir from AZT or d4T improves fat loss and improves lipid parameters compared to abacavir<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Continued use of a thymidine analogue may limit benefit from rosiglitazone when used to treat lipoatrophy\" href=\"https:\/\/i-base.info\/htb\/8586\" rel=\"bookmark\">Continued use of a thymidine analogue may limit benefit from rosiglitazone when used to treat lipoatrophy<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Tenofovir is non-inferior to adefovir for the treatment of hepatitis B in HBV-HIV co-infected patients\" href=\"https:\/\/i-base.info\/htb\/7421\" rel=\"bookmark\">Tenofovir is non-inferior to adefovir for the treatment of hepatitis B in HBV-HIV co-infected patients<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Reports from the conference As is customary for this scientific meeting, Retrovirus this year provided an opportunity for important research. Abstracts from this meeting are posted to the conference website, and many pdf for poster presentations are also already online: &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,59],"class_list":["post-7456","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-croi-2005"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/7456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=7456"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/7456\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=7456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=7456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=7456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}